Lilly Sues Accord Over Gemzar ANDA
Eli Lilly & Co. has sued Intas Pharmaceutical Ltd. marketing arm Accord Healthcare Inc. over its attempt to introduce a generic version of Gemzar, marking the drug giant's latest move to...To view the full article, register now.
Already a subscriber? Click here to view full article